MONA FAWZY: Open Payments
NPI 1508381708 · PRINCETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 61 payments from 17 companies in 2025. Trend: 2023 $496 · 2024 $1,086 · 2025 $1,107
Food & beverage: $1,007Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $210 |
| ABBVIE INC. | 16 | $193 |
| Novartis Pharmaceuticals Corporation | 6 | $145 |
| Amgen Inc. | 8 | $129 |
| Galderma Laboratories, L.P. | 5 | $91 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $60 |
| Incyte Corporation | 3 | $52 |
| PFIZER INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| UCB, Inc. | 2 | $31 |
Products named: TREMFYA, SKYRIZI, Otezla, COSENTYX, NEMLUVIO, OPZELURA, RINVOQ, CIBINQO.
Industry payments across NJ — which companies pay providers there.
